We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.67B
AUM Growth
-$255M
Cap. Flow
-$501M
Cap. Flow %
-18.76%
Top 10 Hldgs %
64.43%
Holding
673
New
208
Increased
118
Reduced
162
Closed
161

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$268M
2
AMZN icon
Amazon
AMZN
+$226M
3
BSX icon
Boston Scientific
BSX
+$55.2M
4
PYPL icon
PayPal
PYPL
+$42.9M
5
ADBE icon
Adobe
ADBE
+$33.3M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$241M
2
MU icon
Micron Technology
MU
+$171M
3
INTC icon
Intel
INTC
+$163M
4
MSFT icon
Microsoft
MSFT
+$121M
5
AAPL icon
Apple
AAPL
+$112M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.16%
2 Technology 19.26%
3 Healthcare 6%
4 Financials 5.81%
5 Energy 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HI
351
DELISTED
Hillenbrand
HI
$538K 0.02%
+19,354
New +$680K
OSG
352
Octave Specialty Group
OSG
$210M
$536K 0.02%
47,858
+22,581
+89% +$264K
VIR icon
353
Vir Biotechnology
VIR
$1.5B
$534K 0.02%
71,348
+11,723
+20% +$102K
INVA icon
354
Innoviva
INVA
$1.49B
$531K 0.02%
27,524
-80,753
-75% -$1.49M
CNNE icon
355
Cannae Holdings
CNNE
$644M
$526K 0.02%
27,598
-93,838
-77% -$1.8M
FOXA icon
356
Fox Class A
FOXA
$26.6B
$524K 0.02%
12,371
-42,136
-77% -$1.64M
IMKTA icon
357
Ingles Markets
IMKTA
$1.62B
$523K 0.02%
+7,012
New +$516K
AR icon
358
Antero Resources
AR
$11.4B
$516K 0.02%
+18,000
New +$510K
PCRX icon
359
Pacira BioSciences
PCRX
$974M
$515K 0.02%
+34,200
New +$585K
MNKD icon
360
MannKind Corp
MNKD
$1.26B
$505K 0.02%
+80,293
New +$461K
CAT icon
361
Caterpillar
CAT
$385B
$501K 0.02%
+1,280
New +$442K
FBIN icon
362
Fortune Brands Innovations
FBIN
$5.73B
$498K 0.02%
5,567
-6,862
-55% -$526K
CROX icon
363
Crocs
CROX
$6.63B
$495K 0.02%
3,419
-5,444
-61% -$743K
OTIS icon
364
Otis Worldwide
OTIS
$27.7B
$494K 0.02%
+4,749
New +$452K
REZI icon
365
Resideo Technologies
REZI
$3.67B
$484K 0.02%
+24,047
New +$477K
DNA icon
366
Ginkgo Bioworks
DNA
$500M
$484K 0.02%
+59,415
New +$595K
SHOE
367
Shoe Station Group
SHOE
$437M
$484K 0.02%
+11,040
New +$451K
CDP icon
368
COPT Defense Properties
CDP
$4.14B
$474K 0.02%
+15,622
New +$445K
VRRM icon
369
Verra Mobility
VRRM
$720M
$471K 0.02%
+16,929
New +$475K
EHC icon
370
Encompass Health
EHC
$12.5B
$470K 0.02%
+4,867
New +$437K
NOW icon
371
ServiceNow
NOW
$132B
$465K 0.02%
2,600
-142,645
-98% -$23.5M
EGY icon
372
Vaalco Energy
EGY
$622M
$461K 0.02%
80,370
-23,796
-23% -$150K
GOLF icon
373
Acushnet Holdings
GOLF
$5.34B
$458K 0.02%
+7,183
New +$474K
KELYA icon
374
Kelly Services Class A
KELYA
$544M
$452K 0.02%
21,128
-9,446
-31% -$200K
EVER icon
375
EverQuote
EVER
$900M
$451K 0.02%
+21,401
New +$489K
13 14
15
16 17

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q3 2024 Portfolio in Review

As of Q3 2024, Caxton Associates (New York) held 673 positions worth $2.67B, down 8.7% from $2.93B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Caxton Associates (New York) withdrew a net $501M in Q3 2024, closing 161 positions and reducing 162 holdings. Its most notable exit was Micron Technology, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Caxton Associates (New York) opened a new position in Boston Scientific worth $58.7M.

  • Caxton Associates (New York)'s largest Q3 2024 buy was Boston Scientific: 700,000 shares worth $58.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2024, an estimated $268M increase.
  • Caxton Associates (New York)'s biggest Q3 2024 reduction was Citigroup, cutting an estimated $241M.
  • Caxton Associates (New York) fully exited Micron Technology in Q3 2024, selling an estimated $171M.
  • Caxton Associates (New York)'s ten largest holdings make up 64% of its $2.67B portfolio in Q3 2024.
  • Caxton Associates (New York) opened 208 new positions and closed 161 in Q3 2024.
  • Caxton Associates (New York)'s portfolio value fell 8.7% quarter-over-quarter to $2.67B.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.